M. Lovestamadrian et al., PREECLAMPSIA IS A POTENT RISK FACTOR FOR DETERIORATION OF RETINOPATHYDURING PREGNANCY IN TYPE-1 DIABETIC-PATIENTS, Diabetic medicine, 14(12), 1997, pp. 1059-1065
The aim of the present study was to examine the influence of pregnancy
on deterioration of retinopathy in patients with Type 1 diabetes mell
itus. Sixty-five pregnant Type 1 diabetic women attending the Universi
ty Hospital in Lund were studied retrospectively. The degree of retino
pathy, and levels of HbA(1c) and blood pressure 12 months before, duri
ng, and 6 months after pregnancy were compared of those of 56 non-preg
nant Type 1 diabetic women matched for age and duration of diabetes. F
or all patients, sight-threatening deterioration of retinopathy did no
t differ between the pregnancy group (9/65) and the control group (6/5
6). Over time, pregnant patients had lower HbA,, levels than controls
(p<0.001). Pregnant patients with sight-threatening deterioration of r
etinopathy had higher HbA(1c) levels than those without (p=0.028 and t
he decrement in HbA,, between the 6-14th and the 20th week of gestatio
n was more pronounced (p = 0.006). In those patients who developed pre
-eclampsia during pregnancy, deterioration of retinopathy ocurred more
frequently compared to those without pre-eclampsia (4/8 vs 5/65; p=0.
005). In conclusion, sight-threatening deterioration of retinopathy wa
s not more common during pregnancy in IDDM patients than among age-and
duration-matched control patients. In pregnant patients, deterioratio
n of retinopathy was associated with the pregestational degree of meta
bolic control as well as with a rapidly improved glycaemic control ach
eived during pregnancy. Among those in whom deterioration occurred dur
ing pregnancy, pre-eclampsia was a potent risk factor. (C) 1997 by Joh
n Wiley & Sons, Ltd.